The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
Musters AH, Broderick C, Prieto-Merino D, Chiricozzi A, Damiani G, Peris K, Dhar S, De A, Freeman E, Arents BWM, Burton T, Bosma ALL, Chi CC, Fletcher G, Drucker AM, Kabashima K, de Monchy EF, Panda M, Wall DR, Vestergaard C, Mahé E, Bonzano L, Kattach L, Napolitano M, Ordoñez-Rubiano MF, Haufe E, Patruno C, Irvine AD, Spuls PI, Flohr C.
Musters AH, et al. Among authors: panda m.
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):365-381. doi: 10.1111/jdv.18613. Epub 2022 Oct 12.
J Eur Acad Dermatol Venereol. 2023.
PMID: 36169355
Free PMC article.